Gerard C. Grosveld

27.0k citations

158 papers · 21.9k indexed · 12 hit papers · h-index 65

Hematology top 0.05%
- Acute Myeloid Leukemia Research 47
- Chronic Myeloid Leukemia Treatments 45
Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 27
Oncology top 0.2%
Immunology top 0.2%
Molecular Biology top 0.2%
- Genomics and Chromatin Dynamics 18
- Nuclear Structure and Function 11
- Protein Degradation and Inhibitors 10
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 28
Rheumatology
- Eosinophilic Disorders and Syndromes 10

Co-authors: Jan M. van Deursen Annelies de Klein Nora Heisterkamp James R. Downing James N. Ihle John Groffen Scott W. Hiebert Tsukasa Okuda
Cited by: Hematology Genetics Oncology
Journals: Molecular and Cellular Biology (18 papers)Blood (16 papers)Nature (8 papers)
Partner nations: United States Netherlands Germany

In The Last Decade

Gerard C. Grosveld

158 papers receiving 21.2k citations

Hit Papers

12 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2001 Nature Medicine
1998 Cell
1998 Cell
1997 Cell
1996 Cell
1996 Nature
1996 Nature
1995 Science
1985 Nature
1983 Nature
1983 Nature
1982 Nature

Peers

Countries citing papers authored by Gerard C. Grosveld

Since Specialization

Citations

This map shows the geographic impact of Gerard C. Grosveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard C. Grosveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard C. Grosveld more than expected).

Fields of papers citing papers by Gerard C. Grosveld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard C. Grosveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard C. Grosveld. The network helps show where Gerard C. Grosveld may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gerard C. Grosveld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerard C. Grosveld Line = papers co-authored together Gerard C. Grosveld links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lysosomes and Cancer Progression: A Malignant Liaison Frontiers in Cell and Developmental Biology ·Eda Machado,Ida Annunziata,Diantha van de Vlekkert,Gerard C. Grosveld,Alessandra d’Azzo	2021	69
2	ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer Science Advances ·Franklin C. Harwood,Ramon I. Klein Geltink,Brendan P. O’Hara,Monica Cardone,Laura J. Janke,David Finkelstein,曹学军,Leena Paul,Peter J. Houghton,Gerard C. Grosveld	2018	83
3	Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis JCI Insight ·Yu Fukuda,Yao Wang,Shangli Lian,J.A. Lynch,Shinjiro Nagai,Nitzan Goldschmidt,Ayten Kandilci,Laura J. Janke,Geoffrey Neale,Yiping Fan,Brian P. Sorrentino,Martine F. Roussel,Gerard C. Grosveld,John D. Schuetz	2017	36
4	High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells Leukemia Research ·Atul Rao,Agyemong Attah-Poku,河南省第十届戏剧大赛评委会,Müge Sayitoğlu,Gerard C. Grosveld,Monica Cardone,Vwuxfwxuh Dqg,Ramon I. Klein Geltink,Uğur Özbek,Dr Geraldine Lane,Yasuhiro Ogoshi,Sema Anak,Serap Karaman,Gülyüz Öztürk,Alice Bobée,Ayten Kandilci	2015	3
5	Mapping of MN1 Sequences Necessary for Myeloid Transformation PLoS ONE ·Ayten Kandilci,Fatemeh Jalalvand,Laura J. Janke,Geoffrey Neale,Vwuxfwxuh Dqg,Gerard C. Grosveld	2013	9
6	PAX3-FOXO1 Induces Cannabinoid Receptor 1 to Enhance Cell Invasion and Metastasis Cancer Research ·Amy D. Marshall,Irina V. Lagutina,Gerard C. Grosveld	2011	43
7	Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo Cancer Research ·Trisha M. Wise‐Draper,幸則日下,Edwin James,真由美石井,Kathryn A. Wikenheiser‐Brokamp,Mark A. Currier,Timothy P. Cripe,Gerard C. Grosveld,Susanne I. Wells	2009	75
8	Overexpression of N-Myc Rapidly Causes Acute Myeloid Leukemia in Mice Cancer Research ·Hiroyuki Kawagoe,Ayten Kandilci,Tanya A. Kranenburg,Gerard C. Grosveld	2007	57
9	Negative Regulation of the RelA/p65 Transactivation Function by the Product of the DEK Proto-oncogene Journal of Biological Chemistry ·Morgan A. Sammons,Shan Wan,BURT OCHS,Edwin Mientjes,Gerard C. Grosveld,Brian P. Ashburner	2006	49
10	The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis Molecular and Cellular Biology ·Monica Cardone,Ayten Kandilci,Cintia Carella,Jonas A. Nilsson,Jennifer Brennan,Nina Rimsky,Uğur Özbek,Kelli L. Boyd,John L. Cleveland,Gerard C. Grosveld	2005	38
11	FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts The EMBO Journal ·Philippe R.J. Bois,Gerard C. Grosveld	2003	147
12	Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo Cancer Cell ·Akira Inoue,Markus G. Seidel,Wenshu Wu,Shintaro Kamizono,Adolfo A. Ferrando,Roderick T. Bronson,Hiromi Iwasaki,Koichi Akashi,Akira Morimoto,Johann Hitzler,Tamara I. Pestina,Carl W. Jackson,Ryuhei Tanaka,Garima Wahi,Peter J. McKinnon,Takeshi Inukai,Gerard C. Grosveld,A. Thomas Look	2002	152
13	Stat5 Is Required for IL-2-Induced Cell Cycle Progression of Peripheral T Cells Immunity ·Richard Moriggl,David J. Topham,Stephan Teglund,Veronika Sexl,Catriona McKay,Demin Wang,Angelika Hoffmeyer,Jan van Deursen,Mark Y. Sangster,Kevin D. Bunting,Gerard C. Grosveld,James N. Ihle	1999	477
14	The Nucleoporin CAN/Nup214 Binds to both the Cytoplasmic and the Nucleoplasmic Sides of the Nuclear Pore Complex in Overexpressing Cells Experimental Cell Research ·Judith M. Boer,Jan M. A. van Deursen,Huib J. E. Croes,Jack Fransen,Gerard C. Grosveld	1997	19
15	The restricted expression pattern of the POU factor Oct-6 during early development of the mouse nervous system Mechanisms of Development ·Ronald Zwart,Ludo A. M. Broos,Gerard C. Grosveld,Dies Meijer	1996	39
16	Translocation of BCR to chromosome 9: A new cytogenetic variant detected by FISH in two Ph‐negative, BCR‐positive patients with chronic myeloid leukemia Genes Chromosomes and Cancer ·Anne Hagemeijer,Arjan Buijs,E.M.E. Smit,Bart Janssen,Silviu Brindusoiu,S.S. Chen,Gerard C. Grosveld	1993	83
17	can , a Putative Oncogene Associated with Myeloid Leukemogenesis, May Be Activated by Fusion of Its 3‣ Half to Different Genes: Characterization of the set Gene Molecular and Cellular Biology ·Marieke von Lindern,Sjozèf van Baal,J. Wiegant,Anton K. Raap,Anne Hagemeijer,Gerard C. Grosveld	1992	102
18	Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene Baillière s Clinical Haematology ·Marieke von Lindern,Maarten Fornerod,NachtergaeleLode,Sjozèf van Baal,Martine Jaegle,André Revel,D. Bootsma,Gerard C. Grosveld	1992	52
19	Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis. The Journal of Experimental Medicine ·Claus R. Bartram,Johannes W.G. Janssen,R. Becher,Annelies de Klein,Gerard C. Grosveld	1986	33
20	c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. The Journal of Experimental Medicine ·John Groffen,Nora Heisterkamp,John Stephenson,M. Patricia Juárez,Annelies de Klein,Gerard C. Grosveld,D. Bootsma	1983	83

About Gerard C. Grosveld

Gerard C. Grosveld is a scholar working on Hematology, Genetics and Molecular Biology, having authored 158 papers that have together received 21.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (47 papers), Chronic Myeloid Leukemia Treatments (45 papers), Acute Lymphoblastic Leukemia research (28 papers), Chronic Lymphocytic Leukemia Research (27 papers), Genomics and Chromatin Dynamics (18 papers), Nuclear Structure and Function (11 papers), Eosinophilic Disorders and Syndromes (10 papers) and Protein Degradation and Inhibitors (10 papers). The work is most often cited by research in Hematology (6.8k citations), Genetics (3.8k citations) and Oncology (6.6k citations). Gerard C. Grosveld has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Jan M. van Deursen, Annelies de Klein, Nora Heisterkamp, James R. Downing, James N. Ihle, John Groffen, Scott W. Hiebert, Tsukasa Okuda, Claus R. Bartram and Marieke von Lindern. Their work appears in journals such as Molecular and Cellular Biology, Blood, Nature, Cell and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact